News

News

Atlas Genetics appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer

Expanded Board and Blue Chip Investors Position Company for Global Reach Bath, UK, 3 October, 2017. Atlas Genetics Ltd., the ultra-­rapid, point-­of-­care (POC) testing company for women’s and family health,…

News

Innovate UK awards Atlas Genetics £2m SBRI phase II Contract

Project to support adoption of the io® rapid diagnostic platform into UK sexual health clinics Bath, UK, 14 August, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company,…

News

Atlas Genetics raises $35m in Series D fundraising

Financing global launch and menu development of Atlas Genetics’ io® molecular testing system Bath, UK, 23 January, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces…

News

O’Neill anti-microbial resistance report highlights the necessity for the Atlas io® test platform for infectious diseases

CE-marked CT test gives results in 30 minutes Bath, UK, 02 June 2016. Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the STI Point-Of-Care (POC) molecular diagnostics company, today notes…

News

Atlas Genetics wins SBRI grant from Innovate UK

New Multiplex test for Sexually Transmitted Infections (STIs) Bath, UK, 15th March, 2016. Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces…